---
title: "Astonea Labs Ltd (544409) — Share Price, Financials & Analysis"
symbol: "544409"
company: "Astonea Labs Ltd"
canonical: "https://tapetide.com/stocks/544409"
isin: "INE0TG901011"
nse_symbol: "ASTONEALABSLTD"
bse_code: "544409"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 303.8
generated_at: "2026-09-13T18:21:44.906Z"
---

# Astonea Labs Ltd (544409)

Canonical page: https://tapetide.com/stocks/544409

## Company

- **NSE Symbol:** ASTONEALABSLTD
- **BSE Code:** 544409
- **ISIN:** INE0TG901011
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-06-03
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** astonea.org

## About

Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:54.573393Z.

- **Market Cap:** ₹303.8 Cr
- **Classification:** SME
- **P/E (reported):** 67.2
- **Book Value:** ₹54.35
- **Price to Book:** 5.32
- **Dividend Yield:** 0%
- **ROE:** 7.9%
- **ROCE:** 11.34%
- **Debt to Equity:** 0.74
- **Revenue (yearly):** ₹148.1 Cr
- **Net Income:** ₹4.5 Cr
- **EBITDA:** ₹13.9 Cr
- **52-Week High:** ₹301.3
- **52-Week Low:** ₹118
- **RSI (14):** 12.81

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 86%
- **Data coverage:** 71%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 25.93 | 9% |
| growth | 92.41 | 9% |
| momentum | 98.17 | 12% |
| ownership | 28.56 | 24% |
| quality | 36.71 | 22% |
| valuation | 18.24 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 5.32 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 41.3 days to 74.2 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -247.57% | -9.64% | -277.97% |
| ebitda margin growth | -40.2% | — | — |
| net income growth | -16.67% | 97% | — |
| revenue growth | 51.59% | 30% | — |
| roce | -59.43% | — | — |
| roe | -72.81% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 47 | 66 | 81 |
| Expenses | 41 | 61 | 73 |
| Operating Profit | 7 | 5 | 8 |
| OPM % | 14 | 8 | 10 |
| Other Income | 0 | 0 | 0 |
| Interest | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 3 |
| Profit before tax | 3 | 2 | 4 |
| Tax % | 24 | 20 | 20 |
| Net Profit | 2 | 1 | 3 |
| EPS in Rs | 2.76 | 1.35 | 2.95 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 30 | 67 | 80 | 98 | 148 |
| Expenses | 24 | 60 | 68 | 82 | 134 |
| Operating Profit | 6 | 7 | 12 | 15 | 14 |
| OPM % | 19 | 11 | 15 | 16 | 9 |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Interest | 2 | 2 | 3 | 4 | 3 |
| Depreciation | 4 | 4 | 4 | 5 | 5 |
| Profit before tax | 1 | 1 | 5 | 7 | 6 |
| Tax % | 57 | 39 | 24 | 24 | 20 |
| Net Profit | 0 | 1 | 4 | 5 | 5 |
| EPS in Rs | 0.62 | 1.68 | 5.36 | 6.93 | 4.3 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 8 | 8 | 11 |
| Reserves | 3 | 4 | 4 | 11 | 47 |
| Borrowings | 30 | 36 | 42 | 53 | 43 |
| Other Liabilities | 16 | 20 | 26 | 32 | 46 |
| Total Liabilities | 53 | 64 | 81 | 103 | 146 |
| Fixed Assets | 21 | 21 | 22 | 26 | 31 |
| CWIP | 0 | 0 | 2 | 4 | 8 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 32 | 44 | 57 | 73 | 101 |
| Total Assets | 53 | 64 | 81 | 103 | 146 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -5 | -1 | 8 | 9 | -14 |
| Cash from Investing Activity | -3 | -3 | -8 | -11 | -20 |
| Cash from Financing Activity | 8 | 4 | 0 | 2 | 34 |
| Net Cash Flow | 0 | 0 | -1 | 0 | 0 |
| Free Cash Flow | -8 | -4 | 0 | -2 | -28 |
| CFO/OP | -75 | -9 | 71 | 70 | -88 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 235 | 104 | 116 | 142 | 129 |
| Inventory Days | 136 | 121 | 161 | 161 | 125 |
| Days Payable | 273 | 128 | 149 | 144 | 150 |
| Cash Conversion Cycle | 98 | 97 | 128 | 159 | 103 |
| Working Capital Days | 98 | 33 | 28 | 22 | 74 |
| ROCE % | — | 8 | 17 | 17 | 11 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Promoters | 72.3% | 72.3% | 72.3% |
| FIIs | 8.01% | 2.51% | 0% |
| DIIs | 4.55% | 0.35% | 0.07% |
| Government | 0% | 0% | 0% |
| Public | 11.51% | 17.06% | 22.25% |
| Others | 3.62% | 7.77% | 5.38% |
| No. of Shareholders | 1014 | 437 | 376 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 6 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 278.36 | Buy |
| EMA (10) | 280.55 | Buy |
| SMA (20) | 275.6 | Buy |
| EMA (20) | 276.62 | Buy |
| SMA (50) | 269.45 | Buy |
| EMA (50) | 261.03 | Buy |
| SMA (100) | 221.5 | Buy |
| EMA (100) | 234.79 | Buy |
| SMA (200) | 189.94 | Buy |
| EMA (200) | 207.36 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 60.57 | Neutral |
| MACD (12,26,9) | 5.36 | Buy |
| Stochastic (14,3,3) | 86.67 | Sell |
| ADX (14) | 14.72 | Neutral |
| Williams %R (14) | -20 | Neutral |
| ATR (14) | 7.42 | Neutral |
| ROC (12) | 7.04 | Buy |
| Stoch RSI (14) | 72.48 | Neutral |
| UO (7,14,28) | 69.06 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Board Meeting Outcome for Meeting Held On 9Th September 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c483472-c9c2-43e8-a66b-0824d0347e85.pdf) |
| 2026-09-09 | [Appointment Of Internal Auditor](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8e88493-39db-4772-afeb-cdaff846f46a.pdf) |
| 2026-08-21 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f29b0f6a-cd68-4c7f-bd70-ae51129f21d5.pdf) |
| 2026-08-21 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d29cd90d-b9a2-4170-b325-08364a6dfd6d.pdf) |
| 2026-08-21 | [Re-Appointment Of Ms. Pooja Singh As Director Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa290c72-1d8b-4f28-b68a-c4d374a059bb.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9983ac30-e77b-4fa2-a591-7747b68f9aee.pdf) |
| 2026-07-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=012ca7ab-1388-431e-a011-2dee7549bdbc.pdf) |
| 2026-07-24 | [Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 24Th July 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c232c1b-acd6-495e-a607-fba1f8817db8.pdf) |
| 2026-07-24 | [Revision In Re-Appointment Of Tax Auditor](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58017e4c-4f20-4572-89d4-2ee1a047e2ee.pdf) |
| 2026-07-24 | [Notice Of 9Th Annual General Meeting ("AGM") Of The Company For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72ead330-df20-4986-b6e7-d9ba31916f92.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Audited Consolidated Financial Results For The Half Year And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=928c2f29-5db9-4f41-b1e9-8a49f5c0fe57.pdf) |
| 2026-06-20 | [Submission Of Additional Documents With Reference To Earlier Corporate Announcement Dated 30Th May 2026 And BSEs Communication Regarding Signing Of Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9aa584c-f8f5-4d7a-8389-db18e16efbbf.pdf) |
| 2026-05-30 | [Audited Standalone Financial Results For The Half Year And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1245d9f3-8e1d-4952-ba54-e0c7516fb754.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b6d35f5f-856e-43e5-9434-7462eacb6038.pdf) |
| 7h - Sasken to attend Bharat Connect Conference on 9 March 2026 (virtual); Q3 FY26 presentation public. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7h - Sasken to attend Bharat Connect Conference on 9 March 2026 (virtual); Q3 FY26 presentation public.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/21e24e68-af39-4ff7-9be8-e9c778188731.pdf) |
| 6 Feb - Q3 FY26 consolidated revenue ₹250.13 crore, PAT ₹9.14 crore; $57m orderbook; Rs.830.80 lakh exceptional charge. | [Announcement under Regulation 30 (LODR)-Meeting Updates 6 Feb - Q3 FY26 consolidated revenue ₹250.13 crore, PAT ₹9.14 crore; $57m orderbook; Rs.830.80 lakh exceptional charge.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf15f12e-c098-432a-9db1-6ba4e14f3608.pdf) |
| 6 Feb - Q3 FY26 audited: consolidated revenue ₹250.13cr, PAT ₹9.14cr, ₹8.31cr labour-code charge; $57m order book. | [Outcome Of The Board Meeting Held Today From 10.00 Am To 6.20 Pm 6 Feb - Q3 FY26 audited: consolidated revenue ₹250.13cr, PAT ₹9.14cr, ₹8.31cr labour-code charge; $57m order book.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1bc4ba71-a763-4e0f-8d59-50a6fc48b0ad.pdf) |
| 6 Feb - Q3 FY26 audited consolidated revenue ₹250.13 crore, PAT ₹9.14 crore; $57m order book; Rs.830.80 lakh exceptional item. | [Board Meeting Outcome for Outcome Of The Board Meeting Held Today From 10.00 Am To 6.20 Pm 6 Feb - Q3 FY26 audited consolidated revenue ₹250.13 crore, PAT ₹9.14 crore; $57m order book; Rs.830.80 lakh exceptional item.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0001d20-40fa-43a4-9ac6-284437c7d936.pdf) |
| 6 Feb - M S K A & Associates converted to LLP effective Jan 12, 2026; auditors continue; engagement unchanged. | [Intimation On Conversion Of Statutory Auditor'S Firm Into An LLP 6 Feb - M S K A & Associates converted to LLP effective Jan 12, 2026; auditors continue; engagement unchanged.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ea78df83-78df-45b1-9db2-0960b3b14928.pdf) |
| 6 Feb - IT CPC intimation under section 143(1) dated Feb 6, 2026: surcharge demand Rs.1,45,100 for AY2025-26; appealable. | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 6 Feb - IT CPC intimation under section 143(1) dated Feb 6, 2026: surcharge demand Rs.1,45,100 for AY2025-26; appealable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2bb3193f-94c0-487f-9df5-22185f3ffbca.pdf) |
| 31 Mar - Astonea Labs acquired 25.74% (52,00,000 shares) of Damaira for INR 6.25 Crore at INR 12.02/share. | [Announcement under Regulation 30 (LODR)-Acquisition 31 Mar - Astonea Labs acquired 25.74% (52,00,000 shares) of Damaira for INR 6.25 Crore at INR 12.02/share.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/628b6249-f552-4f2f-90ee-f5c6f15ef0c4.pdf) |
| 3 Mar - Regarding Newspaper Publication of EGM Notice and PAS-1 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Mar - Regarding Newspaper Publication of EGM Notice and PAS-1](https://www.bseindia.com/xml-data/corpfiling/AttachHis/630501f2-87df-4d10-adc0-43970e1e46ab.pdf) |
| 29 Apr - Astonea Labs confirms it is not a Large Corporate under SEBI debt rules. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Astonea Labs confirms it is not a Large Corporate under SEBI debt rules.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d443c558-616f-4280-bfc3-202ea079805f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_SASKEN_2011_2012_14092012091208.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fffd94f8-bdba-467f-9b9c-822fe2d91bf9.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac9e5a9d-6e70-44ef-b01e-d3f94d76236c.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/84ed50d5-dcc2-4a0e-a91d-fbd200820b7a.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c9de688-ed93-4eb8-b632-1109e5b91e04.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/928611a7-7709-4869-aa7d-6603cb40cc50.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532663/73307532663.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532663/68629532663_22_07_21.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532663/5326630320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532663/5326630319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:21:44.906Z.